價格 | ¥546 | ¥2294 |
包裝 | 50mg | 500mg |
最小起訂量 | 50mg |
發(fā)貨地 | 上海 |
更新日期 | 2023-10-16 |
中文名稱:替米沙坦 | 英文名稱:Telmisartan |
CAS:144701-48-4 | 純度規(guī)格: >98% |
產品類別: 激動劑抑制劑 |
公告提醒:愛必信所有產品和服務僅用于科學研究,不用于臨床應用及其他用途提供產品和服務(也不為任何個人提供產品和服務)!
抑制劑描述:
產品名稱:Telmisartan
產品別名:替米沙坦
英文別名:Telmisartan
靶點:angiotensin II receptor
CAS:144701-48-4
純度:>98%
外觀:白色或類白色結晶性粉末
保存方法:store at -20℃ for one year(Powder); in DMSO or others solvent store at 2-4℃ for two weeks, at -20℃ for six months.
描述:
Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension.
溶解性:DMSO 10.3 mg/mL (20 mM)
體外研究:
Telmisartan functions as a moderately potent (EC50=4.5 μM), selective PPARγ partial agonist, activating the receptor to 25% to 30% of the maximum level achieved by the full agonists pioglitazone and rosiglitazone. Telmisartan induces adipocyte differentiation of 3T3-L1 cells. Telmisartan causes a 60% to 70% decrease in the expression of ACC2 in murine muscle myotubes. Telmisartan, but not candesartan, another ARB, downregulates RAGE mRNA levels in a dose-dependent manner. Telmisartan decreases basal as well as AGE-induced RAGE protein expression in Hep3B cells. Telmisartan dose-dependently inhibits AGE-induced ROS generation and subsequent CRP gene and protein induction in Hep3B cells. Telmisartan effectively facilitates differentiation of 3T3-L1 preadipocytes. Telmisartan causes a dose-dependent increase in mRNA levels for PPARgamma target genes such as aP2 and adiponectin in both differentiating adipocytes and fully differentiated adipocytes. Telmisartan attenuates 11beta-hydroxysteroid dehydrogenase type 1 mRNA level in differentiated adipocytes.
體內研究:Telmisartan promotes increases in caloric expenditure and protects against dietary-induced weight gain in rats fed with a high-fat, high-carbohydrate diet. Telmisartan reduces the accumulation of visceral fat and decreases adipocyte size to a much greater extent than valsartan and is also associated with a significant reduction in hepatic triglyceride levels in rats fed with a high-fat, high-carbohydrate diet.
產品信息訂購:
產品更多信息請進入愛必信網站咨詢
成立日期 | 2010-12-13 (15年) | 注冊資本 | 2500萬 |
員工人數 | 100-500人 | 年營業(yè)額 | ¥ 1000萬-5000萬 |
主營行業(yè) | 生化試劑,抗體,分子生物學,生物活性小分子 | 經營模式 | 工廠 |
產品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP3年
|
湖北魏氏化學試劑股份有限公司
|
2025-01-06 | |
詢價 |
VIP6年
|
湖北威德利化學試劑有限公司
|
2025-01-06 | |
詢價 |
VIP3年
|
廣州遠達新材料有限公司
|
2025-01-06 | |
詢價 |
VIP4年
|
武漢東康源科技有限公司
|
2025-01-06 | |
詢價 |
VIP2年
|
湖北寶凌化工科技有限公司
|
2025-01-06 | |
¥100 |
VIP5年
|
武漢維斯爾曼生物工程有限公司
|
2025-01-06 | |
詢價 |
VIP7年
|
鄭州艾克姆化工有限公司
|
2025-01-06 | |
詢價 |
VIP3年
|
普善實業(yè)(陜西)有限公司
|
2025-01-06 | |
詢價 |
VIP6年
|
武漢鼎信通藥業(yè)有限公司
|
2025-01-06 | |
詢價 |
VIP16年
|
蘇州法姆醫(yī)藥科技有限公司
|
2025-01-06 |